industry is in a stage of rapid development, its existing problems have become increasingly prominent, including severe product homogenization, low industrial concentration, relatively backward production technologies, and high environmental costs.
Therefore, to further advance the green upgrading of the API industry, the state has introduced a series of measures in recent years to support the high-quality development of the pharmaceutical industry. For instance, four ministries including the Ministry of Industry and Information Technology recently jointly issued the . The document clearly states that efforts will be made to promote the transformation of green production technologies, increase the proportion of green products among bulk APIs, accelerate the development of specialty APIs and high-end custom APIs, and eliminate backward technologies and products in accordance with laws and regulations.
In addition, green development goals for APIs have been set: by 2025, the industrial structure will be more rational, the proportion of APIs produced using green processes will be further increased, and the market share of high-end specialty APIs will rise significantly; industrial layout will be more optimized, technological capabilities will be effectively improved, green standards will be continuously refined, and the level of cleaner production will be notably enhanced. Insiders generally believe that with policy support, enterprises engaged in environmentally compliant specialty APIs and high-end custom APIs will embrace favorable opportunities in the future.
